Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2018 Oct 16;83(1):61–70. doi: 10.1007/s00280-018-3702-9

Table 2.

Odds of high vs. low serum hormone or chemokine concentration based on BMI status (obese vs non-obese) for patients enrolled on the UNC Cancer Survivorship Cohort.

Hormone, Chemokine* Odds Ratio (95% CI) P-value**
CCL2 2.48 (0.87–7.12) 0.090
CCL5 1.07 (0.39–2.98) 0.895
Estrone 1.85 (0.66–5.21) 0.242
Estradiol 8.64 (2.67–28.0) < 0.001
Testosterone 2.14 (0.76–6.06) 0.152
DHT 1.85 (0.66–5.21) 0.242

Odds ratio reference point equals 1.0

*

Concentration of hormone, chemokines were dichotomized at the median.

**

Univariable logistic regression model

***

Obese group n=33, non-obese group n=28